MCRC Trials

HPP404-102 TTP399-106
MCRC is currently enrolling volunteers into the trials listed under "MCRC Trials". If you would like more information concerning any of them click on the name of the trial for a link to details on each study.
HPP404-102
About The Drug: This is an investigational drug designed to reduce food intake and body weight in overweight and obese populations.
Length of Stay: One six hour visit on Day -7, followed one week later by a stay in the clinic of 5 days and 4 nights, followed by six 5-hour outpatient visits during the next 17-day period, followed by a 4-day and 3 night stay in the clinic, and then one final visit
Dates:
  • Cohort #3:  May 2010
  • Cohort #4:  July 2010
Requirements:
  • Age 18 to 54 with a  BMI  28.0 to 39.9
  • NON-SMOKING Healthy Overweight Male or Female
  • FEMALES must be post-menopausal or surgically sterile [unable to bear children]
  • NOT taking any prescription or over-the-counter medications
  • No history of Hepatitis B, Hepatitis C, or HIV
Approximate Payment: To be determined
I am interested in participating in this study; please contact me at: